ARTICLE | Company News
Allergan, Concurrent deal
May 31, 2004 7:00 AM UTC
Concurrent acquired certain rights to AGN's retinoid program, including a preclinical portfolio of retinoid and rexinoid nuclear receptor compounds to treat diabetes, cancer and dermatological disorde...